La. Blomberg et al., EFFECT OF HUMAN PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN ON BLOOD-CELL REGENERATION AFTER BONE-MARROW TRANSPLANTATION, Proceedings of the Society for Experimental Biology and Medicine, 217(2), 1998, pp. 212-218
Pregnancy-specific beta 1-glycoprotein (PSG) is composed of a family o
f highly homologous proteins initially isolated from human placenta an
d pregnancy serum, Recent studies showed that PSGs are also present in
a number of ectopic sites, including uncultured peripheral blood and
bone marrow cells, This report aims at studying the in vivo effect of
the PSGs on murine hematopoiesis. The profile of recovery of blood cel
ls after transplantation of viable nucleated bone marrow cells in gamm
a-irradiated mice with and without the administration of the purified
human protein was studied. Five groups of mice were given 0.1 mu g hum
an serum albumin, 0.1 mu g IL6, 1 mu g PSG, 10 mu g PSG, and 50 mu g P
SG, respectively, per mouse per day consecutively for 20 days, The mic
e were bled once every 2 days, and the platelet and WBC counts were de
termined using a Nebauer hemacytometer (Hausser Scientific, Buffalo, N
Y). The recovery of platelet count after bone marrow transplant was mu
ch faster in mice receiving 1 mu g PSG/day than in animals in any othe
r group. On Day 20 post-transplant, the platelet count of animals in t
his group reached 178,600 +/- 15,759/mu l (mean +/- standard deviation
) which was significantly (P < 0.05) higher than that of any other gro
up, On Day 26, the platelet count reached a low normal value of 190,84
4 +/- 6,380/mu l with a range of 185,420-200,500/mu l. This value was
3-fold higher than that of the control group (68,600 +/- 15,486/mu l i
n the human serum albumin group). Mice given 1 mu g or 10 mu g PSG/day
also had their WBC count recover significantly faster and achieved a
normal value (12,440 +/- 3,680/mu l for the 1-mu g PSG group, and 12,1
54 +/- 3,016/mu l for the 10-mu g PSG group) within the experimental p
eriod, On the other hand, the controls, or mice given 50 mu g PSG/day
did not recover as rapidly and did not achieve a normal WBC count with
in the experimental period. These results suggest that human placental
PSGs enhance platelet and WBC recovery after bone marrow transplant.